The Vanguard Study: Testing a New Way to Screen for Cancer
This is a feasibility (pilot) study of new blood tests designed to screen for many different types of cancer at once. Adults aged 45 to 75 are randomly placed in one of three groups: two groups each get a different multi-cancer detection blood test, and the third is a control group whose blood is stored but not tested with either test. The goal is to see whether a future, larger randomized trial of these tests can work, and to get early information on how well they perform.
You might be able to join if you are between 45 and 75 years old and have not been diagnosed with a solid tumor or blood cancer in the past five years; in situ (very early, non-invasive) cancers and non-melanoma skin cancer do not count, but untreated prostate cancer rules you out no matter when it was diagnosed. You also need to be comfortable giving blood samples and completing questionnaires in English, Spanish, or Arabic (Spanish and Arabic depend on the enrollment hub).
Participants will be placed into different groups to either take a multi-cancer blood test or join a control group. You will give blood samples when you join and one year later, and researchers will also check your medical records and ask you to fill out health surveys.
The study is currently recruiting participants at 45 sites in 13 U.S. states, through 9 enrollment hubs; the VA and military sites enroll only veterans in VA care or people covered by the military health system. It is an important first step in figuring out how well these new cancer screening tests work in real life.
- 1Tests a new blood method to screen for multiple cancers at once.
- 2Open to adults aged 45 to 75 without a recent history of cancer.
- 3Involves giving blood samples, answering surveys, and sharing medical records.
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.